The main mechanisms involved in controlling bone regeneration and calcium homeostasis include changes in plasma PTH, calcitriol, calcium and phosphate, bone regeneration markers due to hypoparathyroidism and hyperparathyroidism, renal failure, daily PTH 1-34 administration, and RANKL inhibition [39]. The gene discussed is PTH; the disease is hypoparathyroidism.